In vivo evaluation of A-56619 (difloxacin) and A-56620: new aryl-fluoroquinolones.

Por Fernandes, P B, Chu, D T, Bower, R R, Jarvis, K P, Ramer, N R, Shipkowitz, N
Publicado em 1986

Susceptibility testing of macrolide antibiotics against Haemophilus influenzae and correlation of in vitro results with in vivo efficacy in a mouse septicemia model.

Por Fernandes, P B, Hardy, D, Bailer, R, McDonald, E, Pintar, J, Ramer, N, Swanson, R, Gade, E
Publicado em 1987

In vitro evaluation of ABT-719, a novel DNA gyrase inhibitor.

Por Flamm, R K, Vojtko, C, Chu, D T, Li, Q, Beyer, J, Hensey, D, Ramer, N, Clement, J J, Tanaka, S K
Publicado em 1995

In vitro and in vivo evaluations of A-80556, a new fluoroquinolone.

Por Clement, J J, Tanaka, S K, Alder, J, Vojtko, C, Beyer, J, Hensey, D, Ramer, N, McDaniel, D, Chu, D T
Publicado em 1994

In vitro and in vivo evaluation of tiacumicins B and C against Clostridium difficile.

Por Swanson, R N, Hardy, D J, Shipkowitz, N L, Hanson, C W, Ramer, N C, Fernandes, P B, Clement, J J
Publicado em 1991

A-61827 (A-60969), a new fluoronaphthyridine with activity against both aerobic and anaerobic bacteria.

Por Fernandes, P B, Chu, D T, Swanson, R N, Ramer, N R, Hanson, C W, Bower, R R, Stamm, J M, Hardy, D J
Publicado em 1988

Comparative antibacterial activities of temafloxacin hydrochloride (A-62254) and two reference fluoroquinolones.

Por Hardy, D J, Swanson, R N, Hensey, D M, Ramer, N R, Bower, R R, Hanson, C W, Chu, D T, Fernandes, P B
Publicado em 1987

In vitro and in vivo evaluation of A-56268 (TE-031), a new macrolide.

Por Fernandes, P B, Bailer, R, Swanson, R, Hanson, C W, McDonald, E, Ramer, N, Hardy, D, Shipkowitz, N, Bower, R R, Gade, E
Publicado em 1986